These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 11409584

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
    Törün T, Tahaoğlu K, Ozmen I, Sevim T, Ataç G, Kir A, Güngör G, Bölükbaşi Y, Maden E.
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
    [Abstract] [Full Text] [Related]

  • 23. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z, Pei X, Yang Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [Abstract] [Full Text] [Related]

  • 24. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB, Jiang RH, Xiao HP.
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [Abstract] [Full Text] [Related]

  • 25. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
    Roongruangpitayakul C, Chuchottaworn C.
    J Med Assoc Thai; 2013 Oct; 96(10):1273-82. PubMed ID: 24350407
    [Abstract] [Full Text] [Related]

  • 26. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.
    Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):805-11. PubMed ID: 22390880
    [Abstract] [Full Text] [Related]

  • 29. [Cases of pulmonary tuberculosis in which kanamycin-resistant tubercle bacilli did not appear even after a long-term administration of kanamycin. Some consideration on the interpretation of drug resistance tests].
    Tsukamura M.
    Kekkaku; 1971 Oct; 46(10):405-8. PubMed ID: 4112456
    [No Abstract] [Full Text] [Related]

  • 30. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM, Yip CW.
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [Abstract] [Full Text] [Related]

  • 31. [Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens].
    Mar'iandyshev AO, Klinberg NM, Shonbina AI, Moroz MI.
    Probl Tuberk; 1997 Jun; (4):19-21. PubMed ID: 9333808
    [Abstract] [Full Text] [Related]

  • 32. Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosis.
    Rao S.
    Respirology; 2004 Aug; 9(3):402-5. PubMed ID: 15363016
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB, Jiang RH, Li L, Xiao HP.
    Int J Tuberc Lung Dis; 2012 Aug; 16(3):358-63. PubMed ID: 22640450
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS, Kumar AM, Claassens M, Banurekha VV, Sekar G, Venkatesan P, Swaminathan S.
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.